Overexpression of thioredoxin reductase 2 (TrxR2) in cancer cells is often considered a critical factor in the complex interplay of tumorigenesis, disease progression, and the resistance to apoptosis, underscoring its significant role in the intricate dynamics of cancer development and survival. This evidence concerns the gene TXNRD2 and cancer.